Caterina Ledda Selected Research

fluor-edenite

1/2022	Dysregulation of microRNAs and tRNA-derived ncRNAs in mesothelial and mesothelioma cell lines after asbestiform fiber exposure.
12/2021	ATG7 immunohistochemical expression in malignant pleural mesothelioma. A preliminary report.
1/2021	Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Study.
4/2020	Defense and protection mechanisms in lung exposed to asbestiform fiber: the role of macrophage migration inhibitory factor and heme oxygenase-1.
1/2020	An In vivo Immunohistochemical Study on MacroH2A.1 in Lung and Lymph-Node Tissues Exposed to an Asbestiform Fiber.
3/2018	Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: a preliminary report.
3/2018	Occupational exposure to fluoro-edenite and prevalence of anti-nuclear autoantibodies.
2/2018	Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.
1/2017	Analysis of fibulin-3 after exposure to asbestos-like fibers.
5/2016	Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Ledda Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 03/2013
12	Malignant Mesothelioma 01/2022 - 01/2015
6	COVID-19 03/2022 - 01/2021
3	Mesothelioma 01/2022 - 05/2016
3	Hepatitis B 01/2021 - 02/2017
3	Inflammation (Inflammations) 01/2020 - 05/2015
2	Infections 01/2022 - 11/2013
2	Lung Diseases (Lung Disease) 01/2020 - 05/2015
2	Carcinogenesis 01/2020 - 06/2018
2	Occupational Stress 01/2020 - 01/2020
2	Heart Diseases (Heart Disease) 12/2019 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2015
2	Multiple Sclerosis 08/2016 - 01/2015
1	Human Influenza (Influenza) 03/2022
1	Breakthrough Infections 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Cadaver (Cadavers) 03/2021
1	Vaccine-Preventable Diseases 01/2021
1	Pleural Diseases 04/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2019
1	Stroke (Strokes) 12/2019
1	Cognitive Dysfunction 12/2019
1	Skin Diseases (Skin Disease) 10/2019
1	Hepatitis C 06/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 05/2017
1	Diabetes Mellitus 02/2017
1	Liver Neoplasms (Liver Cancer) 02/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Noncommunicable Diseases 12/2015
1	Neuromyelitis Optica (Devic's Disease) 01/2015
1	Tourette Syndrome (Tourette's Syndrome) 01/2015
1	Chorea (Rheumatic Chorea) 01/2015
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2015

Drug/Important Bio-Agent (IBA)

10	fluor-edeniteIBA 01/2022 - 05/2016
7	AsbestosIBA 12/2021 - 05/2015
5	VaccinesIBA 03/2022 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 07/2020 - 01/2015
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2020
2	CytokinesIBA 01/2020 - 11/2013
2	Indicators and Reagents (Reagents)IBA 01/2020 - 02/2018
2	ArsenicIBA 01/2018 - 03/2013
2	PesticidesIBA 01/2017 - 01/2015
2	Amphibole AsbestosIBA 01/2017 - 05/2016
1	mRNA VaccinesIBA 01/2022
1	mesoglycanIBA 01/2022
1	Transfer RNA (tRNA)IBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 03/2021
1	RNA Splicing FactorsIBA 01/2021
1	CarcinogensIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Benzene (Benzole)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	NitritesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	macroH2A histoneIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	HomocysteineIBA 12/2019
1	Matrix Metalloproteinases (MMPs)IBA 10/2019
1	Surface Antigens (Surface Antigen)IBA 06/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 06/2018
1	Aquaporins (Water Channels)IBA 06/2018
1	Mineral Fibers (Mineral Fiber)IBA 03/2018
1	ApolipoproteinsIBA 01/2018
1	CadmiumIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 05/2017
1	AflatoxinsIBA 02/2017
1	SteroidsIBA 02/2017
1	Oral ContraceptivesIBA 02/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	Pharmaceutical PreparationsIBA 08/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015
1	Methylprednisolone FDA LinkGeneric 01/2015
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015
1	Natalizumab (Tysabri)FDA Link 01/2015
1	Rituximab (Mabthera)FDA Link 01/2015
1	Interleukin-8 (Interleukin 8)IBA 11/2013
1	Pyrethrins (Pyrethroids)FDA Link 11/2013
1	Interleukin-2 (IL2)IBA 11/2013
1	AlloysIBA 04/2013
1	Heavy MetalsIBA 03/2013

Therapy/Procedure

1	Personal Protective Equipment 02/2021
1	Mediterranean Diet 12/2015
1	Immunotherapy 01/2015
1	Plasma Exchange 01/2015